Cite
Xu Y, Pan Q, Wang C, et al. Genetic polymorphisms in oxidative stress-related genes are associated with clinical outcome in patients with advanced non-small cell lung cancer receiving tyrosine kinase inhibitors. Am J Cancer Res. 2014;4(6):934-42
Xu, Y., Pan, Q., Wang, C., He, C., Su, Z., Guo, X., Zhang, J., Kong, M., Ke, S., Zhang, J., Chen, B., Sheng, H., & Zhang, X. (2014). Genetic polymorphisms in oxidative stress-related genes are associated with clinical outcome in patients with advanced non-small cell lung cancer receiving tyrosine kinase inhibitors. American journal of cancer research, 4(6), 934-42.
Xu, Yunhua, et al. "Genetic polymorphisms in oxidative stress-related genes are associated with clinical outcome in patients with advanced non-small cell lung cancer receiving tyrosine kinase inhibitors." American journal of cancer research vol. 4,6 (2014): 934-42.
Xu Y, Pan Q, Wang C, He C, Su Z, Guo X, Zhang J, Kong M, Ke S, Zhang J, Chen B, Sheng H, Zhang X. Genetic polymorphisms in oxidative stress-related genes are associated with clinical outcome in patients with advanced non-small cell lung cancer receiving tyrosine kinase inhibitors. Am J Cancer Res. 2014 Nov 19;4(6):934-42. eCollection 2014. PMID: 25520881; PMCID: PMC4266725.
Copy
Download .nbib